Prof. Gibson presents an overview of the effects of macrolide treatment, as an add-on therapy for asthma and COPD.

Prof. Gibson presents evidence that azithromycin treatment reduces exacerbations in adults with obstructive airways disease (asthma or COPD) with ongoing symptoms and exacerbations despite treatment with long-acting bronchodilators and inhaled corticosteroids (ICS), if indicated. Patients should be screened prior to treatment, to confirm no QTc prolongation, cardiac arrhythmia or hearing loss. Treatment dose is 500mg, 3 times per week (or 250mg daily) for up to 12 months.

This presentation was recorded in May 2018.

свернуть